Table 2.

Disease characteristics of patients with cancer with COVID-19 and association with mortality

	Alive	Deceased	P
Total	157 (72%)	61 (28%)
Males	91 (72%)	36 (28%)	0.6
Females	66 (73%)	25 (27%)	0.6
Median age (range)	66 (10–92)	76 (10–92)	0.0006
Race			0.602
Caucasian	14 (64%)	8 (36%)
Hispanic	58 (76%)	18 (24%)
African American	67 (73%)	25 (27%)
Asian	5 (71%)	2 (29%)
Other	13 (62%)	8 (38%)

	N/total alive (%)	N/total deceased (%)
ICU admission	8 (5%)	15 (24%)	9.10E-05
Ventilator support	10 (6%)	35 (57%)	1.74E-15
Hemodialysis	10 (6%)	6 (10%)	0.37
Metastasis (solids only)	27 (22%)	15 (37%)	0.06
Active cancer (<1 yr)	60 (38%)	32 (52%)	0.09
Active chemotherapy	34 (22%)	8 (13%)	0.2
Immunotherapy	4 (3%)	1 (2%)	1
Radiotherapy	38 (24%)	11 (18%)	0.33
DM	53 (34%)	27 (44%)	0.116
HTN	100 (64%)	47 (77%)	0.047
Chronic lung disease	34 (22%)	28 (46%)	0.0003
Chronic kidney disease	33 (21%)	21 (34%)	0.052
Coronary artery disease	24 (15%)	19 (31%)	0.012
CHF	18 (11%)	15 (25%)	0.019